PuSH - Publication Server of Helmholtz Zentrum München

48 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
21.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
22.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
23.
van der Laan, S.W.* et al.: Cystatin C and cardiovascular disease: A mendelian randomization study. J. Am. Coll. Cardiol. 68, 934-945 (2016)
24.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat. Genet. 47, 1294-1303 (2015)
25.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility, and BRCA1-mediated DNA repair. Obstet. Gynecol. 70, 758-762 (2015)
26.
Holmes, M.V.* et al.: Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36, 539-550 (2015)
27.
Huffman, J.E.* et al.: Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood 126, e19-e29 (2015)
28.
Lunetta, K.L.* et al.: Rare coding variants and X-linked loci associated with age at menarche. Nat. Commun. 6:7756 (2015)
29.
Lunetta, K.L.* et al.: Corrigendum: Rare coding variants and X-linked loci associated with age at menarche. Nat. Commun. 6:10257 (2015)
30.
Swerdlow, D.I.* et al.: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351-361 (2015)
31.
Baumert, J.J. et al.: No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: Results from meta-analyses of 80,607 subjects. PLoS ONE 9:e111156 (2014)
32.
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*): Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
33.
Ellis, J.* et al.: Large multiethnic candidate gene study for C-reactive protein levels: Identification of a novel association at CD36 in African Americans. Hum. Genet. 133, 985-995 (2014)
34.
Holmes, M.V.* et al.: Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA(2))-V isoenzyme in coronary heart disease modified mendelian randomization analysis using PLA2G5 expression levels. Circ. Cardiovasc. Genet. 7, 144-150 (2014)
35.
Keller, M.F.* et al.: Trans-ethnic meta-analysis of white blood cell phenotypes. Hum. Mol. Genet. 23, 6944-6960 (2014)
36.
Kraja, A.T.* et al.: Pleiotropic genes for metabolic syndrome and inflammation. Mol. Genet. Metab. 112, 317-338 (2014)
37.
Lange, L.A.* et al.: Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233-245 (2014)
38.
Stitziel, N.O.* et al.: Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014)
39.
Tragante, V.* et al.: Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am. J. Hum. Genet. 94, 349-360 (2014)
40.
Yoneyama, S.* et al.: Gene-centric meta-analyses for central adiposity traits in up to 57412 individuals of European descent confirm known loci and reveal several novel associations. Hum. Mol. Genet. 23, 2498-2510 (2014)